http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1175804-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K9-005 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J17-00 |
| filingDate | 1981-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1984-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf4e66069be60543a9e62f1c2226c3e8 |
| publicationDate | 1984-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-1175804-A |
| titleOfInvention | Immunologically active dipeptidyl 5-0, 6-0-acyl- 2- amino-2-deoxy-d-gluofuranose derivatives and methods of preparation |
| abstract | ABSTRACT OF THE DISCLOSURE Immunologically active compounds of the formula: (I,) I II III wherein R1 is C1-7 alkyl, substituted C1-7 alkyl; phenyl; or substituted phenyl; R2 is hydrogen; or C1-10 alkyl; R3 and R4 may be the same ofd different and are each independiently acyl of the formula: where X is -O-, -S-, or ; R9, R10 and R12 may be the same of different and are each independently hydrogen; C1-20 alkyl; C1-20 alkylcarbonyloxy; amino; benzyl; C1-20 alkoxymethyl; or C1-20 alkylamido; r is 0 or 1; s is 0 or 1; and t is 0-20, provided that s may only be o when r and t are greater than 0, or when r is 0 and R11 is amino, phenyl, substituted phenyl, 1-adamantyl, or heterocycle selected from the group consisting of 2- or 3-furyl, 2- or 3-thienyl, 2- or 3-pyrrolidinyl, 2-, 3-, or 4-pyridyl, and 1-tetrazolyl, said hetero-cycle optionally substituted with C1-20 alkylcarbonyl; and R11 is hydrogen; C1-30 alkyl; C2-30 alkenyl: C1-30 alkoxy: phenyl; C1-20 alkylsulfonyl; or cholesteryl; and R4 may additionally be hydrogen; R5 is hydrogen; or R5-R6 together is -CH2-CH2-CH2: R6 is hydrogens C1-7 alkyl; hydroxymethyl; mercapto-nethyl; benzyl; or substituted benzyl; R7 and R8 may be the same or different and are each independently COOR or CONR'R", where R is hydrogen or C1-7 alkyl, and R' and R" are each independently hydrggen or C1-3 alkyl; when R2 is C1-10 alkyl, the steraochemistry at asym-metric center I can be either ? or ?; when R6 is not hydxoqen, the storeochemistry at asymmetric center II is ?; the atereochemistry at asymmetric center III is ?. |
| priorityDate | 1980-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 129.